Stem Cell Revolution is your front-row seat to the future of medicine! Hosted by the team at Hope Biosciences, this podcast brings you the latest in this ever evolving field. We don’t just talk about breakthroughs, we document them in real time. From groundbreaking clinical trials to patient stories and regulatory shifts, we’re living the revolution as it happens.
Join us as we explore how stem cells are transforming medicine, challenging outdated paradigms, and shaping a new era in healthcare. This is more than a podcast—it’s a movement. Subscribe now and experience the revolution with us!
The Real Appearance of Stem Cells Explained | Stem Cell Revolution | Episode 33
What Do Stem Cells Actually Look Like?Have you ever noticed that some stem cell treatments look cloudy, while others are clear, yellow, pink, or even red?Why do they look so different? And more importantly, what's actually inside those syringes?In this episode of Stem Cell Revolution, we're breaking down the science behind stem cells, PRP, bone marrow, cord blood, and exosomes. We'll explore why their appearances vary, how many actual stem cells these preparations may contain, and why not everything marketed as a "stem cell treatment" is the same.What visual clues or product details have you noticed when learning about stem cell research? Share your thoughts in the comments and subscribe for more discussions on regenerative medicine. 🧬Learn MoreWebsite: https://www.hope.bio/X (Twitter): https://x.com/hopebiosciencesInstagram: https://www.instagram.com/hope.bio/Facebook: https://www.facebook.com/share/1Qk9jgqq8W/?mibextid=wwXIfrLinkedIn: https://www.linkedin.com/company/hopebio/YouTube Channel: https://www.youtube.com/@hopebiosciences
15 Sept 2026
Why Most Clinical Trials Never Reach Approval | Stem Cell Revolution | Episode 32
More than 90% of drugs that enter clinical trials never reach FDA approval. In regenerative medicine and stem cell research, that statistic is often misunderstood. A missed endpoint does not always mean mesenchymal stem cells failed. Sometimes the dose, the patient group, or the measurement itself was wrong. 🔍On this episode of Stem Cell Revolution, host Donna Chang and co-host Jan Shultis unpack how clinical trials actually work. They walk through preclinical animal studies, Phase 1 safety research, Phase 2 efficacy studies often called the valley of death, Phase 3 pivotal trials, and Phase 4 post-market data collection. Only about 8% of investigational products complete that path. Success in a mouse does not reliably translate to people.The conversation focuses on trial design. Endpoints must be locked in before a study begins and cannot be rewritten when unexpected signals appear. Regulators often favor patient-reported outcomes and quality of life, not only imaging or blood tests. Cell therapy adds further complexity: living cells are harder to transport than shelf-stable drugs, and freezing a product to solve logistics can change how it performs at scale.Using lessons from multiple sclerosis and Parkinson’s disease research, they show how dosing intervals, placebo groups, publication standards, and predefined populations can turn promising biology into a public “failure.” They argue every trial should be published, because even unexpected results teach the field how cellular therapy and immune modulation behave in real patients.Understanding these mechanics helps viewers read headlines more carefully and see why regenerative medicine moves slowly, and why careful iteration still matters.What do you think a clinical trial should measure first, how a patient feels or what a scan shows? Comment below and subscribe for more conversations on stem cell research. 💬Learn MoreWebsite: https://www.hope.bio/X (Twitter): https://x.com/hopebiosciencesInstagram: https://www.instagram.com/hope.bio/Facebook: https://www.facebook.com/share/1Qk9jgqq8W/?mibextid=wwXIfrLinkedIn: https://www.linkedin.com/company/hopebio/YouTube Channel: https://www.youtube.com/@hopebiosciences
17 Aug 2026
Questions You Must Ask Before Stem Cell Treatment | Stem Cell Revolution | Episode 31
How do you know if a stem cell therapy is legitimate? In an era of rising interest in regenerative medicine, patients face a flood of claims about cellular therapeutics. This episode of Stem Cell Revolution unpacks the practical questions that help separate credible science from marketing.Host Donna Chang and Jan Shultis walk through a clear framework for evaluating stem cell companies and treatments. They discuss why understanding basic cell biology matters before any conversation with a provider, how to identify cell type and source, and why manufacturing quality control and product-specific data are non-negotiable. Listeners learn the difference between mixed cell populations and pure populations, the importance of donor testing for allogeneic products, and why third-party research cannot substitute for data generated on the actual product being offered.Whether you are exploring options for yourself or a loved one, this episode equips you with the scientific literacy and skepticism needed to ask better questions and make more confident decisions in regenerative medicine.What questions do you ask when evaluating a stem cell treatment? Share your thoughts below and subscribe for more conversations on the science of cellular therapy.Learn MoreWebsite: https://www.hope.bio/X (Twitter): @hopebiosciencesInstagram: @hope.bioFacebook: https://www.facebook.com/share/1Qk9jgqq8W/?mibextid=wwXIfrLinkedIn: https://www.linkedin.com/company/hopebio/YouTube Channel: https://www.youtube.com/@hopebiosciences
Who has been a guest on Stem Cell Revolution
Names identified in recent episode analyses. Showing up to five guests.
Dr Lester Martínez-López
Dr Charles Cox
Dr Aijun Wang
Dr Anthony Atala
Michael Policastro
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
3 ratings
Spotify
5.0 / 5
2 ratings
Podcast Authority Score: 39 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
47
Social presence
94
YouTube
0
Engagement
32
Contact Stem Cell Revolution
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Stem Cell Revolution?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
